- $2.57bn
- $2.29bn
- $831.52m
- 94
- 27
- 99
- 86
Annual income statement for Calix, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 52 W | 52 W | 52 W | 52 W | 52 W |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 541 | 679 | 868 | 1,040 | 832 |
Cost of Revenue | |||||
Gross Profit | 267 | 357 | 435 | 518 | 454 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 504 | 605 | 815 | 1,014 | 875 |
Operating Profit | 36.8 | 73.9 | 52.6 | 25.6 | -43 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 34.3 | 72.7 | 54 | 34.8 | -31.6 |
Provision for Income Taxes | |||||
Net Income After Taxes | 33.5 | 238 | 41 | 29.3 | -29.7 |
Net Income Before Extraordinary Items | |||||
Net Income | 33.5 | 238 | 41 | 29.3 | -29.7 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 33.5 | 238 | 41 | 29.3 | -29.7 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.639 | 3.51 | 0.595 | 0.423 | -0.452 |